The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Bayer Schering Pharma AGEU/1/03/249/016

Main Information

Trade NameVivanza
Active SubstancesVardenafil hydrochloride trihydrate (micronized)
Dosage FormOrodispersible tablet
Licence HolderBayer Schering Pharma AG
Licence NumberEU/1/03/249/016

Group Information

ATC CodeG04BE Drugs used in erectile dysfunction
G04BE09 vardenafil


License statusAuthorised
Licence Issued27/06/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back